Future Biome y Heritas SA acuerdan colaborar para que el prebiótico propiedad de Future Biome pueda ser recomendado e incluido en los planes de hábitos de los participantes del Programa Rewel, de Héritas SA.
Sobre la base de este acuerdo, Future Biome proporcionará a Héritas SA su producto, aún en fase final del proceso de validación, para que puedan ser incluidos en los planes de hábitos en individuos participantes del Programa Rewel. Esto se realizará a consideración de las nutricionistas del programa en función de los datos de la microbiota intestinal de los participantes. Los prebióticos son sustancias que estimulan y modulan el crecimiento y función de bacterias beneficiosas en el intestino. BiotaBliss de Future Biome es una fibra prebiótica producida a partir de micelios de hongos cultivados por vía líquida mediante fermentación en biorreactores, que está demostrando seguridad y eficacia durante su validación. El Programa Rewel se caracteriza por realizar el estudio genético necesario para establecer la composición del microbioma intestinal de cada individuo. Esta alianza colaborativa significará asociar el screening del estado basal de la microbiota intestinal con el impacto que un ingrediente de estas características puede tener sobre la mejora de su composición y diversidad para la toma de mejores decisiones nutricionales y de hábitos de vida.
Martín Vazquez, CSO y co-fundador expreso: “estamos encantados de colaborar con Future Biome ya que conocemos de cerca la calidad de sus investigaciones y la seriedad con la que han trabajado durante el proceso de validación. Es gratificante poder asistir a startups de esta calidad en sus primeras etapas de crecimiento”.
Martín Larre, CEO de Future Biome, comentó: “estamos entusiasmados de unir fuerzas con Héritas y su innovador servicio Rewell, líderes en microbioma y medicina de precisión en la región. Este partnership refleja nuestro compromiso conjunto de transformar la salud a través de soluciones basadas en ciencia e innovación, impulsando el bienestar de las personas de manera personalizada y sostenible a través de su microbioma”.
Acerca de Héritas
Héritas is a precision medicine company with nine years of experience operating in Latin America through two innovative business divisions dedicated to enhancing healthcare through proprietary genetic tests and services. The clinical diagnostics division offers genomic diagnostic tests and reports for clinical genomics, oncology, human microbiome and reproductive genomics, along with telehealth consultations, empowering patients and physicians with deep genetic insights to make informed health decisions. Its prevention division, Rewell, focuses on preventive care by offering direct-to-consumer solutions that include DNA and microbiome testing kits and telehealth sessions, guiding consumers to achieve personalized health and nutrition objectives.
Acerca de FutureBiome
Future Biome is a startup at the forefront of health and nutrition innovation, leveraging the transformative potential of the microbiome to create precision prebiotics for personalized well being. Future Biome patent technology combines bioinformatics and biotechnology to develop innovative prebiotic therapies, with a particular focus on fungi-derived innovations. By targeting the gut microbiome, we empower individuals with sustainable, science-driven tools to enhance health outcomes, bridging the gap between precision medicine and precision nutrition.
Through our pioneering approach, we deliver prebiotics that are more effective, customizable, and targeted than traditional options, unlocking new possibilities in preventive care and wellness.
Future Biome and Héritas SA signed a collaboration agreement to recommend (Use) the prebiotic Biotabliss in individuals participating in the Rewel Program.
Future Biome and Heritas SA agree to collaborate so that the prebiotic owned by Future Biome can be recommended and included in the habit plans of participants in the Rewel Program, of Héritas SA.
Based on this agreement, Future Biome will provide Héritas SA with its product, which is still in the final phase of the validation process, so that it can be included in the habit plans of individuals participating in the Rewel Program. This will be done at the discretion of the program’s nutritionists based on the data of the participants’ intestinal microbiota. Prebiotics are substances that stimulate and modulate the growth and function of beneficial bacteria in the intestine. BiotaBliss by Future Biome is a prebiotic fiber produced from fungal mycelia grown in liquid form by fermentation in bioreactors, which demonstrates safety and efficacy during its validation. The Rewel Program is characterized by carrying out the genetic study necessary to establish the composition of the intestinal microbiome of each individual. This collaborative alliance will mean associating the screening of the basal state of the intestinal microbiota with the impact that an ingredient of these characteristics can have on the improvement of its composition and diversity for making better nutritional decisions and lifestyle habits.
Quote from Martín V
“We are delighted to collaborate with Future Biome since we know first-hand the quality of their research and the seriousness with which they have worked during the validation process. It is gratifying to be able to assist startups of this quality in their early stages of growth”.
Quote from Martín Larre
“We are excited to join forces with Héritas and its innovative Rewell service, which are leaders in microbiome and precision medicine in the region. This partnership reflects our joint commitment to transforming health through solutions based on science and innovation, promoting people’s well-being in a personalized and sustainable way through their microbiome”.